ClinicalTrials.Veeva

Menu

Vascular Health and Risk Factors in Children With Down Syndrome

Utah System of Higher Education (USHE) logo

Utah System of Higher Education (USHE)

Status

Completed

Conditions

Down Syndrome
Cardiovascular Risk Factor
Atherosclerosis

Treatments

Other: Evaluate vascular disease risk factors in children with Down Syndrome
Other: Determine the associations between cardiovascular disease risk factors and markers of early atherosclerosis in children with Down Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT04735874
00127761

Details and patient eligibility

About

This is a prospective, multicenter, cross-sectional study to evaluate prevalence of vascular risk factors in children with Down Syndrome and to determine the association between vascular disease risk factors and objective markers of early atherosclerosis.

Enrollment

55 patients

Sex

All

Ages

10 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All children with Down Syndrome (10.0-18.0 years of age)
  • Children with translocations and mosaicism
  • Children with and without CHD

Exclusion criteria

  • Patients with a history of hypoplastic arch, coarctation or catheter or surgical based aorta interventions
  • Patients who are currently treated or have been treated with chemotherapy for cancer or a myeloproliferative disorder within 1 year of the study
  • Participants whose parent/legally authorized representative (LAR) perceives the child is not able to cooperate with vascular imaging studies

Trial design

55 participants in 1 patient group

Children ages 10.0 to 18.0
Treatment:
Other: Evaluate vascular disease risk factors in children with Down Syndrome
Other: Determine the associations between cardiovascular disease risk factors and markers of early atherosclerosis in children with Down Syndrome

Trial contacts and locations

1

Loading...

Central trial contact

Adam L Ware, MD; Andrea Curless

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems